# Can Latency of Action in Infraclavicular Brachial Plexus Block be Shortened With Warmed Bupivacaine?

> **NCT03346993** · PHASE1 · COMPLETED · sponsor: **Erzurum Palandöken State Hospital** · enrollment: 60 (actual)

## Conditions studied

- Effect Increased

## Interventions

- **DRUG:** Bupivacaine Hydrochloride 5 MG/ML

## Key facts

- **NCT ID:** NCT03346993
- **Lead sponsor:** Erzurum Palandöken State Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-01
- **Primary completion:** 2016-07-01
- **Final completion:** 2017-01-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03346993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03346993, "Can Latency of Action in Infraclavicular Brachial Plexus Block be Shortened With Warmed Bupivacaine?". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03346993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*